Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

Many authors have suggested using a cephalosporin as an alternative to penicillin. Casey and Pichichero performed a meta-analysis of 35 randomized, controlled trials comparing penicillin with ...

Ceftobiprole is a fifth-generation cephalosporin antibiotic that has ... had limited activity against certain strains of Pseudomonas aeruginosa, emphasizing the need for susceptibility testing ...